---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-102041"
form_type: "8-K"
ticker: "WW"
cik: "0000105319"
company_name: "WW INTERNATIONAL, INC."
filed_at: "2023-04-14T23:59:59+00:00"
generated_at: "2026-06-17T01:47:08.205014+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# WW International completes $132M acquisition of telehealth platform Sequence

## Summary
- Total consideration $132M: ~$64.2M cash (incl. $25.8M of Sequence cash), ~$34.7M stock (8M shares at $4.34), plus $16M deferred on each of Apr 10, 2024 and 2025.
- Sequence is a subscription telehealth platform providing access to healthcare providers specializing in chronic weight management and insurance navigation.
- CEO Sima Sistani cites expansion into clinical weight management medications as a natural next step, leveraging WeightWatchers' core strengths.
- Company intends to file required financial statements for Sequence and pro forma information within 71 days.

## SEC filing metadata
- accession: 0001193125-23-102041
- form_type: 8-K
- ticker: WW
- cik: 0000105319
- company_name: WW INTERNATIONAL, INC.
- filed_at: 2023-04-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105319/000119312523102041/0001193125-23-102041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105319/000119312523102041/d483518d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-102041
- JSON: https://secwatch.observer/filing/0001193125-23-102041.json
- Plain text: https://secwatch.observer/filing/0001193125-23-102041.txt

## Key facts
- M&A Transactions
  WW INTERNATIONAL, INC. completed an acquisition involving Weekend Health, Inc., doing business as Sequence for an aggregate amount equal to $132.0 million (closed 2023-04-10).
  - Action: acquisition
  - Counterparty: Weekend Health, Inc., doing business as Sequence
  - Consideration: an aggregate amount equal to $132.0 million
  - Closing: 2023-04-10
  source text: Health continued as a wholly-owned subsidiary of the Company (the “Acquisition”). As consideration for the Acquisition, the Company agreed to pay an aggregate amount equal to $132.0 million, subject to the adjustments set forth in the Merger Agreement (the “Merger Consideration”). Subject to the terms and conditions of the Merger Agreement, the Merger Consideration
  evidence_url: https://www.sec.gov/Archives/edgar/data/105319/000119312523102041/0001193125-23-102041-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.